Gilead Sciences Inc (GILD)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 16,085,000 | 14,443,000 | 14,772,000 | 15,996,000 | 30,296,000 |
| Total current liabilities | US$ in thousands | 11,280,000 | 11,237,000 | 11,610,000 | 11,397,000 | 9,759,000 |
| Current ratio | 1.43 | 1.29 | 1.27 | 1.40 | 3.10 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $16,085,000K ÷ $11,280,000K
= 1.43
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets. Gilead Sciences, Inc.'s current ratio has fluctuated over the past five years as follows:
- In 2023, the current ratio was 1.43, indicating that the company had $1.43 in current assets for every $1 in current liabilities. This represents an improvement from the previous year.
- In 2022, the current ratio was 1.29, which suggests a slight decrease in liquidity compared to 2021.
- In 2021, the current ratio was 1.27, reflecting a relatively stable liquidity position.
- In 2020, the current ratio was 1.40, which was higher than the two previous years, implying better short-term liquidity.
- In 2019, the current ratio was 3.10, significantly higher than the subsequent years, indicating a very strong liquidity position in that year.
Overall, Gilead Sciences, Inc. has maintained a current ratio above 1 in each of the past five years, indicating a generally healthy ability to meet its short-term obligations. However, fluctuations in the ratio over the years suggest varying levels of liquidity and highlight the importance of monitoring the company's current asset and liability management.
Peer comparison
Dec 31, 2023